← All indications
Bevacizumab
An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.
Drugs by status
Phase 4 trials (3)
Phase 3 trials (3)
Phase 2 trials (19)
Other trials (1)
An anti-VEGF humanized murine monoclonal antibody. It inhibits VEGF RECEPTORS and helps to prevent PATHOLOGIC ANGIOGENESIS.
Phase 4 trials (3)
Phase 3 trials (3)
Phase 2 trials (19)
Other trials (1)